Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CNS Pharmaceuticals, Inc. - Common Stock
(NQ:
CNSP
)
6.510
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CNS Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Rami Levin as President and Chief Executive Officer
December 17, 2025
Via
Investor Brand Network
CNS Pharmaceuticals Announces CEO Transition
December 17, 2025
Via
ACCESS Newswire
Researchers Use Supplements to Produce Remarkable Outcomes in Brain Cancer Treatment
December 16, 2025
Via
Investor Brand Network
Optimal Treatment Timing Could Boost Cancer Therapy Efficacy
December 10, 2025
Via
Investor Brand Network
Nasal Drops Hold Promise in Fighting Deadly Brain Cancer
December 05, 2025
Via
Investor Brand Network
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast
December 04, 2025
Via
Investor Brand Network
Common Drug for Blood Pressure Could Slow Glioblastoma
November 25, 2025
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q3 Results and Advances Lead Candidate TPI 287 Toward Phase 2 GBM Study
November 17, 2025
Via
Investor Brand Network
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 17, 2025
Via
ACCESS Newswire
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Targets Glioblastoma with Innovative Therapies, Addressing One of Oncology’s Greatest Unmet Needs
November 14, 2025
Via
Investor Brand Network
Wegovy, Ozempic Could Reduce Deaths Resulting from Colon Cancer
November 14, 2025
Via
Investor Brand Network
Topics
Death
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 10, 2025
Via
Benzinga
New Implants Defy Necessity of Brain Surgery Against Cancer
November 10, 2025
Via
Investor Brand Network
CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting
November 10, 2025
Via
ACCESS Newswire
Review Shows That Neurocognitive Functioning Declines in Patients with CNS Cancers
November 06, 2025
Via
Investor Brand Network
What Patients Need to Know About the Remission Rate of Glioblastomas
October 28, 2025
Via
Investor Brand Network
Scientists Uncover Possible Driver of ‘Chemo Brain’
October 27, 2025
Via
Investor Brand Network
Virtual Brain Tumors Could Transform How Cancer is Treated
October 17, 2025
Via
Investor Brand Network
New AI Tool Boosts Precision Medicine in Treating CNS Cancers
October 13, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Scientists Stunned Upon Discovering Glioblastoma Erodes Skull Tissue
October 09, 2025
Via
Investor Brand Network
Scorpion Venom Shows Promise in Brain Tumor Treatment
September 30, 2025
Via
Investor Brand Network
Rogue Rings of DNA Expose Brain Tumor Secrets
September 22, 2025
Via
Investor Brand Network
New Research Suggests Dietary Change Could Improve Glioblastoma Treatment Outcomes
September 18, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 16, 2025
Via
Benzinga
Why Webtoon Entertainment Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
↗
September 16, 2025
Via
Benzinga
NCI Halts Funding for Consortium Conducting Trials on Childhood Brain Cancers
September 05, 2025
Via
Investor Brand Network
CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
Via
ACCESS Newswire
Study Finds Link Between Head Injuries and Elevated Brain Cancer Risk
September 02, 2025
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Drug Development and Market Potential on BioMedWire Podcast
August 27, 2025
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today